Back to search

Article

The Study of Yin-Chen-Hao-Tang Preventing and Treating Alcoholic Fatty Liver Disease Through PPAR Signaling Pathway Based on Network Pharmacology and RNA-Seq Transcriptomics

2021-09-13

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Alcoholic fatty liver disease (AFLD) is the first stage of the alcoholic liver disease course. Yin-Chen-Hao-Tang (YCHT) has a good clinical effect on the treatment of AFLD, but its molecular mechanism has not been elucidated. In this study, we tried to explore the molecular mechanism of YCHT in improving hepatocyte steatosis in AFLD mice through network pharmaco...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b59b3dd8-cb50-50f5-8c2b-554d287e1df7
DOI
10.21203/rs.3.rs-818720/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Study of Yin-Chen-Hao-Tang Preventing and Treating Alcoholic Fatty Liver Disease Through PPAR Signaling Pathway Based on Network Pharmacology and RNA-Seq TranscriptomicsDOI 10.21203/rs.3.rs-818720/v1
Network Pharmacology Reveals the Multiple Mechanisms of Xiaochaihu Decoction in the Treatment of Non-alcoholic Fatty Liver DiseaseSemantic proximity
Mechanisms of Cynarine for treatment of Non-alcoholic Fatty Liver Disease Based on the Integration of Network Pharmacology, Molecular Docking and Cell ExperimentSemantic proximity
Identify Key Active Ingredients and Molecular Mechanisms of Jiangzhi Decoction on Non-alcoholic Fatty Liver Disease by Network Pharmacology AnalysisSemantic proximity
Mechanisms of Yinchen combined with Huangbai against Non-alcoholic fatty liver disease based on Network pharmacology, Molecular docking and Molecular Dynamics SimulationsSemantic proximity
Huanglian-Hongqu herb pair improves nonalcoholic fatty liver disease via NF-κB/NLRP3 pathway in mice: network pharmacology, molecular docking and experimental validationSemantic proximity
Exploration of potential targets and mechanisms of naringenin in the treatment of nonalcoholic fatty liver disease through network pharmacologySemantic proximity
A network-based approach reveals the dysregulated transcriptional regulation in non-alcohol fatty liver diseaseSemantic proximity
The pharmacodynamic and differential gene expression analysis of PPAR α/δ agonist GFT505 in CDAHFD-induced NASH modelSemantic proximity
Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology and molecular dockingSemantic proximity
Alcoholic fatty liver disease inhibited the co-expression of Fmo5 and PPARα to activate the NF-κB signaling pathway, thereby reducing liver injury via inducing gut microbiota disturbance&nbsp;Semantic proximity
Polyene Phosphatidyl Choline Injection Regulates Lipid Homeostasis via AKT-PDE3-PKA in MiceSemantic proximity
Mechanistic Study of Yang-gan-jie-yu Granules in Treating Postmenopausal Metabolic-Associated Fatty Liver Disease Based on Transcriptomics and Network PharmacologySemantic proximity
Select a neighboring publication to make it the new centre.